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Silver-nanoparticlesAbstract The spreading of infectious diseases and the increase in incidence of drug resistance
among pathogens have made the search for new antimicrobials inevitable, similarly is the cancer
disease. Nowadays, there is a growing need for biosynthesized nanoparticles (NPs) as they are
one of the most promising and novel therapeutic agents of biological origin. The unique physico-
chemical properties of the nano silver (Ag-NPs) as well as nano gold (Au-NPs) when combined with
the growth inhibitory capacity against microbes lead to an upsurge in the research on NPs and their
potential application as antimicrobials. The phytochemicals of marine algae that include hydroxyl,
carboxyl, and amino functional groups can serve as effective metal reducing agents and as capping
agents to provide a robust coating on the metal NPs. The biosynthesis of Ag-NPs and Au-NPs
using green resources is a simple, environmentally friendly, pollutant-free and low-cost approach.
The biosynthesized NPs using algae exerted an outstanding antimicrobial and cytotoxic effect.
 2016 Production and hosting by Elsevier B.V. on behalf of Academy of Scientific Research &
Technology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Contents
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Nanotechnology is a modern technology that studies nanome-
ter sized objects [89]. It is expected that nanotechnology will be
developed at different levels such as materials, medical devices
and systems. Generally, the synthesized silver nanoparticles
have applications in the field of nanomedicines and this opens
the way to develop AgNPs synthesized by different microbes
against various human pathogens [3].
The progress in nanotechnology research is starting to have
an impact in the biomedical and industrial fields. Not only
does this progress raise hopes in patient populations regarding
improved specificity and lower doses, but it raises concerns in
environmental and occupational fields due to a lack of toxicity
studies and other unwanted side effects as well. Nano-Ag par-
ticles, with dimensions ranging from tens to hundreds of
nanometers, have unique features that differ from bulk mate-
rial properties. The increased relative surface area of nanopar-
ticles (NPs), compared with fine and ultrafine particle bulk
material, can lead to changes in its physical, chemical, mechan-
ical, thermal as well as electrical, magnetic, and luminescent
properties [91].
Over the past few contracts, inorganic NPs, whose struc-
tures exhibit novel functionality and improved physical as well
as chemical and biological characteristics due to their nano
scale size, have released much interest. To date, metallic NPs
are usually prepared from noble metals, i.e., Ag, Pt, Au and
Pd [96]. Among inorganic agents, silver is the metal of choice
in the fields including biological systems as well as living
organisms and medicine [102] because it has been used most
extensively since ancient times to fight infections and control
blighter. Silver NPs (Ag-NPs) have gained special interest over
other metal NPs (e.g., gold and copper) because the surface
plasmon resonance energy of it is located away from the inter
band transition energy. Tremendous applications were found
by the Ag-NPs in the fields of catalysis, optoelectronics, detec-
tion and diagnostic, antimicrobials and therapeutics. The Ag-
NPs can be exploited in medical and pharmaceutical due to
their low toxicity to human cells and high thermal stability
[122].
The Macedonians were the first to use the application of sil-
ver plates to achieve better wound healing, perhaps it was the
first try to prevent or treat surgical infections. Hippocrates
used silver preparations for the treatment of ulcers and pro-
moted them medically because it was mentioned in a pharma-
copeia published in Rome in 69 B.C.E. [48]. Various silver
compounds and their derivatives have been used to treat
burns, wounds and infections as antimicrobial agents [2]. Its
risk benefit ratio is advantageous. Various silver compounds
and their derivatives have been used to treat burns, wounds
and infections as antimicrobial agents.The use of gold in medicine (Chrysotherapy) has been used
since antiquity. Gold was used to treat diseases in ancient cul-
tures in Egypt, China and India. They treated diseases such as
small pox, syphilis, skin ulcers, and measles [50,110,45,68]. In
the past few decades, several organo-gold complexes have ema-
nated with hopeful antitumor, antimicrobial, antimalarial, and
anti-HIV activities [45,129].
Nano scaled-Ag and Nano scaled-Au are not new and it
was likely created in the 4th century A.D. In the 1990s,
researchers at the British Museum determined the average
diameter of the gold and silver particles in the glass to be
70 nm. The Lycurgus Cup therefore represents what is likely
one of the first uses of Ag- NPs and Au-NPs [37].
Faraday in 1857 was the first who described the chemical
reduction of transition metal salts to generate zero-valent par-
ticles; following this early detection, Lea [75], described the
reduction of silver nitrate (AgNO3) in the presence of triso-
dium citrate, which was subsequently extended to gold NPs
by reducing chloroauric acid with sodium citrate [132].
The Ag-NPs and Au-NPs particles play an important role
in nanobiotechnology and biomedicine to control the drug ren-
itent bacteria. It was evident that people that become infected
with drug renitent microorganisms usually spend more time in
the hospital and require a form of treatment that use two or
three different antibiotics and is less efficient, more toxic,
and more expensive. The Ag-NPs are preferred option because
they are nontoxic to the human body at low concentrations
and have broad spectrum antimicrobial properties
[115,28,52,104]. The Ag-NPs have been studied as an ambience
for antibiotic delivery, and for the production of disinfecting
filters and coating materials [80,64].
Singaravelu et al. [123] made a novel extracellular synthesis
of monodisperse Au-NPs using marine alga, Sargassum wightii
Greville. This report is the first in which a marine alga has been
used to synthesize highly stable extracellular Au-NPs in a rel-
atively short time period compared with that of other biolog-
ical procedures. As a matter of fact, 95% of the bioreduction
of AuCl4 ions happened within 12 h at stirring condition.
Kaushik et al. [61] concluded that the alternative and eco-
friendly process for synthesis of metallic NPs is a critical need
through using biological systems. There are many recent stud-
ies which specified the antimicrobial activity of the biosynthe-
sized Au-NPs using seaweeds [107,35,134].
2. Characterization of the metal nanoparticles
Characterization of the metal NPs is performed using a variety
of analytical techniques as transmission or scanning electron
microscopy (TEM, SEM), atomic force microscopy (AFM),
dynamic light scattering (DLS), X-ray photoelectron spec-
troscopy (XPS), powder X-ray diffractometry (XRD), Fourier
Figure 2 Diverse applications of biologically synthesized
nanoparticles. Modified from Joyce Nirmala et al. [58].
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troscopy [51,135]. In order to characterize the morphology of
the NPs morphology including, particle size, shape, crys-
tallinity, fractal dimensions, pore size and surface area, the
aforementioned techniques are applied.
2.1. Preparation of silver & gold nanoparticles
The development of biologically enliven experimental process
for synthesis of NPs is evolving into an important branch of
nanotechnology [112,96]. Various methods are applied for
the synthesis of nanoparticles including chemical, electrochem-
ical, c-radiation photochemical, laser ablation, microwave irra-
diation, thermal decomposition and sono-chemical synthesis
[76]. Their contribution depends critically on their size, shape
and composition. The most popular preparation of silver nano
colloids is chemical reduction of silver salts by sodium borohy-
dride or sodium citrate. Most of these reducing agents lead to
either environmental toxicity or biological perils; therefore, the
trend has shifted to biogenic production of NPs. The advan-
tages of biosynthesis of NPs over conventional methods are
summarized in Fig. 1 [58].
2.2. Biogenic production of silver and gold nanoparticles by
microalgae and seaweeds
The green chemistry synthetic route for the NPs production
have several advantages over those chemically synthesized as
good control on the size distribution, such method can be
potentially used for the large-scale synthesis for medical appli-
cations [136]. The synthesis of NPs from a wide diversity of
marine resources proved to be one of the recent and most inno-
vative areas of research (see Fig. 2).
Marine life has always been a unique fountain of bioactive
compounds with formidable impact in the field of pharmaceu-
tics and medicine. The marine ecosystem has captured a major
attention in recent years. Various biologically active com-
pounds have been isolated and screened for pharmacological
activity from dissimilar marine provenience. Therefore, marine
biological resources can be considered an essential for nan-
otechnology [81]. Researchers had been interested to synthe-Figure 1 Advantages of biosynthesis of nanoparticles over
conventional methods. Modified from Joyce Nirmala et al. [58].size metallic NPs from marine source because it is thought to
be ecofriendly, nontoxic, environmentally acceptable ‘‘green
procedures”, reduces the down-streaming process making it
very cost effective and the availableness of the source from
the diverse marine ecosystem becomes a much easier task.
The biosynthesized NPs from marine compound offer stabi-
lized NPs through organic compounds present in the marine
source that make them more efficient for both biomedical
and industrial applications [58].
Biological synthesis of Ag-NPs using microorganism has
received overpowering interest because of their potential to
synthesize NPs of various sizes, shapes, and morphology
[66]. Microalgae are primitive microscopic plants, and com-
pared to higher plants and they have important advantages
as cell factories for producing NPs [84]. Microalgae grow
extremely rapidly and double their mass on average ten-
times faster than higher plants [20]. Various microalgae species
are known to reduce metal ions.
Lengke et al. [79] reported the phyto formation of extracel-
lular Ag-NPs by photoautotrophic cyanobacterium Plec-
tonema boryanum. Other cyanobacteria, Anabaena, Calothrix
and Leptolyngbya have also been reported to biosynthesize
intracellular nano-Au and nano-Ag [12]. Mahdieha et al. [85]
reported green biosynthesis of Ag-NPs with a live biomass of
the cyanobacterium Spirulina platensis. The X-ray Diffraction
(XRD) spectrum of NPs confirmed the metallic silver
formation, and the average size of the crystallite was estimated
from the peak profile by the Scherrer method. The synthesized
Ag-NPs had an average size of 11.6 nm.
There are few reports of Au-NPs synthesis using microor-
ganisms [82,78,79]. The biosynthesis of Au-NPs by some
prokaryotic and eukaryotic algal members had also been
reported by many workers [15,16,95]. Lengke et al. [78] have
reported the bioproduction of Au-NPs using the cyanobac-
terium P. boryanum. Intracellular biosynthesis of Au nanorod
by the cyanobacterium Nostoc ellipsosporum has been wit-
nessed for the first time in laboratory condition. The nano rods
were produced within the cell after uncovering the healthy
growing filaments to 15 mg L1 gold (III) solution (pH 4.5)
for 48 h at 20 C [103].
In single-crystalline silver nanoplates synthesis at room
temperature, proteins in the extract furnish dual function of
Ag+ reduction and shape-control in the nano-Ag synthesis
[55]. The carboxyl groups in aspartic and or glutamine residues
and the hydroxyl groups in tyrosine residues of the proteins
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stated [55]. Cell free extracts of the microalga Chlorella vulgaris
have also been used to bioproduce Au-nanoplates [56].
A simple room-temperature one-pot synthesis based on the
bioreduction ability of the algal extract solution has been
established to produce single-crystalline Au-nanoplates with
triangular and hexagonal shapes in high yield. A protein with
an approximate molecular weight of 28 kDa was isolated and
purified by reversed-phase HPLC; this protein tested positive
for the reduction process of chloroauric acid in aqueous solu-
tion. The isolated protein was then involved in providing the
dual function of AuIII reduction and the size- and shape-
controlled synthesis of the Au-nano plates [56]. Furthermore,
Luangpipat et al. [84] described the intracellular production
of Au-NPs in C. vulgaris as an efficient biological route to pro-
duce Au-NPs which allows the NPs to be easily recovered
remains elusive. They recognized NPs inside intact cells by
transmission electron microscopy (TEM) and confirmed to
be metallic gold by synchrotron based X-ray diffraction and
X-ray absorption spectroscopy. These NPs ranged between
40 and 60 nm in diameter.
Barwal et al. [10] have reported the intracellular and extra
cellular Ag-NP production in the unicellular green microalga
Chlamydomonas reinhardtii. Jena et al. [54] succeeded to syn-
thesize the Ag-NPs using fresh extract and whole cell of micro-
alga Chlorococcum humicola, through the incubation of the
extract and the whole cell with AgNO3. They investigated
and characterized the in vivo and in vitro formation of the
biosynthesized nano-Ag. They concluded that a simple one-
pot in vivo and in vitro bioreduction system in unicellular
microalga has been developed as the protein molecules were
mainly in charge of the biosynthesis of Ag-NPs.
Recently, El-Sheekh and El-Kassas [34] reported the in vivo
biosynthesis of Ag-NPs by different microalgae species that
belong to different groups namely, S. platensis, C. vulgaris
and Scenedesmus obliquus using two different scenarios. The
first was by suspending a thoroughly washed algae biomass
in 1 mM aqueous AgNO3 solution and the second by culturing
algae individually in culture media containing the same con-
centration of AgNO3. The Ag-NPs are well distributed with
the mean average size of 20, 8.0 and 8.8 nm for S. platensis,
C. vulgaris and Sc. obliquus, respectively. Up to the current
knowledge, this is the first report to conclude the biosynthesis
of silver NPs by the green alga Sc. obliquus. FTIR spectral
analyses suggested that proteins and/or polysaccharides may
be responsible for the biosynthesis of Ag-NPs and (–COO–)
of carboxylate ions for stabilizing them.
El-Sheekh and El-Kassas [35] reported for the first time the
phytogenic production of Au-NPs by marine picoeukaryote
alga Picochlorum sp. The alga culture was used as a reductant
for HAuCl4-3H2O resulting in the phytosynthesis of Au-NPs
within 48 h. The particles are biophysically characterized and
the average size of Au-NPs is 11 nm. The FTIR analysis of
the nanocolloid revealed that polysaccharide and protein bio-
molecules in the algae cell do dual function of reducing the
Au3+ ions and stabilizing the phytogenic Au-NPs. The micro-
alga was regarded as potential bio factory for Au-NPs synthe-
sis and serves as a new generation anti-microbial agent with
their unique chemical and biophysical properties.
The mechanism underlying the extraction and synthesis of
NPs is yet to be studied [58]. However, Moghaddam [90]
explained that from protein assay of microalgae, that thepreparation of Ag-NPs is a NADH-dependent reductase.
The reductase enzyme gains electrons from NADH and oxi-
dizes it to NAD+, and then the enzyme is oxidized by the
simultaneous reduction of silver ions forming nano-Ag. In
some cases a nitrate-dependent reductase is responsible for
the bioreduction process, therefore a complex electron shuttle
material may be involved in the biosynthesis process. The con-
formation of protein molecules plays an important role in Ag-
NPs biosynthesis and stabilization.
The bioreduction of silver ions to Ag-NPs using the green
seaweeds Ulva lactuca and red seaweed Gelidiella sp. has also
been reported. The organic compounds present in marine
sources used for synthesis increases their efficiency and help
in stabilizing as well as coating the NPs. Seaweeds constitute
an assortment of phytochemicals like carbohydrates, alkaloids,
steroids, phenols, and saponins as well as flavonoids which aid
in the reduction and stabilization of NPs. The characteristics
of the obtained Ag-NPs were studied using UV–Visible Spec-
troscopy, X-ray Diffraction (XRD) pattern, Scanning Electron
Microscopy (SEM) and Transmission Electron Microscopy
(TEM). The biosynthesized Ag-NPs were predominately
spherical in shape and polydispersed. The Fourier Transform
Infra-Red (FT-IR) spectroscopy analysis has showed that the
synthesized nano-Ag was capped with bimolecular compounds
which are responsible for reduction of silver ions. In addition,
nano-Ag was 22 nm in diameter [60,136].
Kumar et al. [70] demonstrated extracellular synthesis of
Ag-NPs from Sargassum ilicifolium rapidly. The scanning elec-
tron microscope (SEM) and transmission electron microscope
(TEM) analysis showed formation of well dispersed Ag-NPs in
the range of 33–40 nm. They concluded that this method is
simple and rapid for synthesis of colloidal Ag-NPs, which have
been derived through bio-reduction of seaweed S. ilicifolium.
An important potential benefit of the described method is that
the synthesized Ag-NPs are stable. An important potential
benefit of the described method is that they are quite stable
in solution.
Sahayaraj et al. [116], use marine algae Padina pavonica
(Linn.) thallus broth in the extra cellular synthesis of biogenic
Ag-NPs. The biosynthesized Ag-NPs were predominantly
spherical and polydispersed with diameters in the range 10–
72 nm (mean value = 46.8 nm). The authors suggested the
presence of terpenoids that may play a role in the reduction
of metal ions by oxidation of aldehydic groups in the mole-
cules to carboxylic acids.
Arockiya Aarthi Rajathi et al. [4] studied the biological syn-
thesis of antibacterial Au-NPs by brown alga, Stoechospermum
marginatum biomass. Furthermore, the biologically synthe-
sized Au-NPs were found to be effective against bacterial
pathogens. They reported that the reduction of gold chloride
has been carried out by hydroxyl groups present in the diter-
penoids of the brown alga. In addition to this Naveena and
Prakash [94] studied the biological synthesis of Au-NPs using
the marine alga Gracilaria corticata and its application as a
potent antimicrobial and antioxidant agent. They concluded
that this green chemistry approach toward the synthesis of
Au-NPs has many advantages such as ease with which the pro-
cess can be scaled up and economic viability. They added that
the toxicity studies of Au-NPs are a doorway for a new range
of antibacterial and antioxidant agents.
Rajeshkumar et al. [107] used marine brown algae Turbina-
ria conoides for the green synthesis of nano sized-gold. The
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Electron Microscope and Energy Dispersive analysis and the
biosynthesized Au-NPs synthesis was started at 30 min and
completed at 48 h and they were stable for several months.
The recent studies used seaweeds belonging to different
families for the rapid, efficient and fully biophysical character-
ization of Au-NPs. El-Kassas and El-Sheekh [33] used extract
of the red seaweed Corallina officinalis for biosynthesis of
nano-gold particles. These biosynthesized Au-NPs were 14.6
± 1 nm in diameter. Based on the FTIR analysis, the authors
attributed the formation and stabilization of the biosynthe-
sized Au-NPs to the hydroxyl functional group from polyphe-
nols and carbonyl group from algal proteins.
Also, there are two studies considering the application of
brown seaweeds on the bio production of nano sized-gold.
Kayalvizhi et al. [62] compared the synthesis and antimicrobial
potentialities of Ag-NPs and Au-NPs using two brown
macroalgae (seaweeds) extract (Padina tetrastromatica and
Turbinaria ornate). They used scanning electron microscopy
and dynamic light scattering analysis for characterization
and determination the NPs size. The results revealed the parti-
cles with cubical shape with size of 18–90 nm for nano-Ag and
20–90 nm for nano-Au. The Ag NPs and Au NPs appeared to
be linked with hydroxyl and carbonyl groups. It was suggested
also that probably aromatic alcohols and amines are present as
phytochemicals in the two studied algae. Moreover, Varun
et al. [134] studied the green synthesis of nano-Au using aque-
ous extract of brown seaweed Dictyota bartayresiana as the
reducing agent. The carboxylic, amine and polyphenolic
groups were coupled with the green synthesized Au-NPs which
were confirmed by using the techniques of Fourier Transform
Infra-Red (FT-IR) spectroscopy.
3. The products of Ag-NPs & Au-NPs
The products of Ag-NPs & Au-NPs which are already avail-
able for human use include wound dressings, contraceptive
devices, surgical instruments and bone prostheses [18]. Water
purification, food packaging, medical devices and bandages,
clothing, washing machines, food industry to limit bacterial
growth are also among the applications of Ag-NPs [11]. More-
over, dental restoration material and indoor air quality man-
agement recently depend on Ag-NPs [18,53]. Furthermore,
Ag-NPs have been shown to undergo size-dependent interac-
tions with the HIV-1 virus and prevent its binding to the host
cell in vitro [30]. Table 1, presents a few examples of medicalTable 1 Medical products containing Ag-NPs and their application
Product Company Description
ActicoatTM Smith & Nephew Nano crystalline silver wound dr
SilverlineR Spiegelberg Polyurethane ventricular cathete
impregnated with NS
SilvaSorbR Medline Industries
and AcryMed
Antibacterial products: hand gels
dressings, cavity filler
ON-Q
SilverSoakerTM
I-Flow Corporation Silver-NP-coated catheter for dr
deliveryproducts containing Ag-NPs and their applications [17]. More
essentially is the potential for the application of Ag-NPs in the
medication of diseases that target specific cells or organs or
need constant drug concentration in the blood [92,100].
3.1. The antimicrobial activity of Ag-NPs & Au-NPs
Toxicity studies of Ag-NPs on human pathogen opens a door
for a new range of antibacterial and antifungal agents as
revealed by Jones et al. [57]. Additionally, Kim et al. [64] sug-
gested that Ag-NPs possess antimicrobial activity and have
been used medicinally to treat infections in burn treatment.
Ag-NPs are shown to prevent bacterial colonization on various
surfaces such as catheters [125] and human skin. Moreover,
they are known for their antimicrobial activity against several
other viruses, such as hepatitis B, respiratory syncytial virus,
herpes simplex virus type 1, 12 and monkey pox virus. Indeed,
Duran et al. [27] evaluated the potential use of Ag-NPs to con-
trol pathogens depending on their action against pathogenic
bacteria, their toxicity and possible mechanisms of actions.
Vivek et al. [136] studied the biogenic Ag-NPs by Gelidiella
acerosa extract and their antifungal effects against different
fungal pathogens including Humicola insolens (MTCC 4520),
Fusarium dimerum (MTCC 6583), Mucor indicus (MTCC
3318) and Trichoderma reesei (MTCC 3929). The study indi-
cated that Ag-NPs have considerable antifungal activity in
comparison with standard antifungal drug. They recom-
mended further investigation for clinical applications is neces-
sary. Devi and Valentin Bhimba [23], found that the
synthesized Ag-NPs using extracts of Hypnea sp. with the size
range 10–20 nm are more bactericidal against Gram-negative
bacterium (Escherichia coli) than Gram-positive (Staphylococ-
cus aureus) that were isolated from wound specimen. Valentin
Bhimba et al. [133] studied the anticancer and antimicrobial
activities of mangrove derived fungi Hypocrealixii.
Kumar et al. [70] studied the antibacterial activity and
in vitro cytotoxicity assay against brine shrimp using Ag-NPs
synthesized from the marine brown alga S. ilicifolium. They
demonstrated that the antibacterial activity against five clinical
pathogens at various concentrations shows hindrance in
growth at various nanomolar concentrations. Furthermore,
the toxicity of the biosynthesized Ag-NPs against Artemia
salina was evaluated. Moreover, the biosynthesized Ag-NPs
using Padina pavonica (Linn.) were tested against important
pathogens of cotton namely; Fusarium oxysporum f.sp.
vasinfectum and Xanthomonas campestris pv malvacearum thats [17] after permission.
Clinical uses
essing Dressing for a range of wounds including burns and ulcers;
prevents bacterial infection and improves wound healing
r Neurosurgical drain of CSF for hydrocephalus. Also can
be adapted for use as shunts. Antibacterial silver NP
coating prevents catheter-associated infections
, wound Wound dressings and cavity filler prevent bacterial
infection. Hand gels used to disinfect skin in clinical and
personal hygiene purposes
ug Delivery of medication (e.g. local anesthetics or
analgesics), pre- or post-operatively for pain management
or for antibiotic treatment
304 M.M. El-Sheekh, H.Y. El-Kassasare responsible for significant yield losses in cotton worldwide.
The biosynthesized Ag-NPs using P. pavonica inhibited the
growth of the test pathogens as reported by Sahayaraj et al.
[116].
El-Kassas and Attia [31] studied the biosynthesis, charac-
terization and application of Ag-NPs using an extract of the
red seaweed, Pterocladia capillacea. They reported that the
biosynthesized Ag-NPs inhibited the whole panel of the tested
bacteria with a serious specificity toward Bacillus subtilis, sug-
gesting that they are more bactericidal against Gram-positive
bacteria as indicated in Fig. 3.
Emerging and re-emerging viral species are to be considered
a continuing threat to human health because of their distin-
guishing ability to adapt to their current host as well as to
switch to a new host and to evolve scenarios to escape antiviral
measures [36].
Theoretically, any metal could be analyzed for antiviral
activity, however, little endeavor has been done to determine
the interactions of metal NPs with viruses, and only recently
some studies have emerged revealing that metal NPs can be
effective antiviral agents against HIV-1 as recommended by
[30,128,73,74] hepatitis B virus [83], respiratory syncytial virus
[130], herpes simplex virus type 1 [8,9], monkey pox virus [111],
influenza virus [101] and Tacaribe virus [126].
Galdiero et al. [43] stated that the production of HBV RNA
and extracellular virions probably were inhibited by Ag-NPs
and also interaction between the NPs and the double-
stranded DNA of HBV and/or direct binding with viral parti-
cles [83]. Positive results have been reported to control HIV-1
virus via preferential binding to the gp120 glycoprotein knobs.
Due to this interaction, Ag-NPs inhibit the virus from binding
to host cells [30]. The interaction between HIV particles and
Ag-NPs is due to the size of the Ag-NPs since only NPs rang-
ing from 1 to 10 nm were able to bind to the virus. The effi-
ciency of Ag-NPs to inhibit infectivity of a laboratory-
adapted HIV-1 strain at non-cytotoxic concentrations was
decided by in vitro assays, and a dose-dependent inhibition
of viral infectivity was reported [73].
Taking into consideration the herpes virus family, viruses
are divided into a, b and c subgroups. Only eight herpes
viruses are known to commonly infect humans and the remain-
ders are animal herpes viruses infecting a wide variety of ani-
mal species [43]. Symptomatic diseases caused by HSV-1
(prototypic a-herpes virus) are generally restricted to coldFigure 3 Transmission electron micrograph showing morphol-
ogy of Bacillus subtilis. A) Normal bacterial cell; B) Bacterial cell
in the presence of 20 lg mL1 of biosynthesized Ag-NPs using
Pterocladia capillacea extract. X= 10,000 [31].sores of the mouth and keratitis in the eyes, but HSV-1 can
result in life-threatening diseases in certain individuals,
including newborns, patients with HIV or patients experienc-
ing immunosuppressive treatment as previously mentioned
[113]. Sulfonate-capped silver and gold NPs obstruct HSV-1
infections by blocking the attachment of the virus to
the cells and/or by preventing the cell-to-cell spread of the
virus [8,9].
Respiratory Syncytial Virus (RSV) belongs to the family
Paramyxoviridae which infects the epithelium cells of the lungs
and the respiratory tract causing serious respiratory disease,
particularly in children and older people. No vaccine or ade-
quate pharmaceutical compounds are available, underlining
the need for the development of future RSV treatments as sta-
ted [43]. Moreover, Sun et al. [130] have utilized Ag-NPs con-
jugated to various proteins to consider the inhibition of RSV
infection in HEp-2 cell culture. In their study, the capping
agents used for the Ag-NPs were: (1) poly (N-vinyl-2-
pyrrolidone) (PVP); (2) bovine serum albumin (BSA); and
(3) a recombinant F protein from RSV (RF 412). They consid-
ered that a saturated surface capping composed of a natural
biomolecule (BSA) and a biocompatible chemical (PVP) could
be used to mask the pure nano-silver surface and thus would
reduce toxicity without hampering efficacy. In addition, Lu
et al. [83] have analyzed mono-disperse Ag-NPs for their abil-
ity to inhibit Hepatitis B virus (HBV) replication. They con-
cluded that, Ag-NPs were able to inhibit the production of
HBV RNA via a specific interaction between the NPs and
the double-stranded DNA of HBV and/or direct binding with
viral particles as mentioned [43].
Considering the antifungal activity of Au-NPs, Eid et al.
[29], investigated the in vitro release kinetics and associated
antifungal effects of Au-NPs against Penicillium. Their results
provided strong evidence that could warrant the consideration
of Au-NPs as antifungal material.
Ahmada et al. [1], on their study using two nano sized Au-
NPs (7 nm and 15 nm) revealed that the Au-NPs exhibit excel-
lent size dependent antifungal activity and greater biocide
action against Candida isolates for 7 nm sized Au-NPs restrict-
ing the trans membrane H+ efflux of the Candida species than
15 nm sized gold nanoparticles. Rajeshkumar et al. [107] used
marine brown algae Turbinaria conoides for the green synthesis
of nano sized-gold. The synthesized nano-Au was character-
ized using Scanning Electron Microscope and Energy Disper-
sive analysis. The synthesized NPs were used for the
bactericidal activity against Bacillus subtilis, Klebsiella pneumo-
nia and Streptococcus sp.
Naveena and Prakash [94] studied the biological synthesis
of Au-NPs using marine algae Gracilaria corticata and its
application as a potent bactericidal and antioxidant agent.
They concluded that this green chemistry approach toward
the synthesis of Au-NPs has many advantages such as ease
with which the process can be scaled up and economic viabil-
ity. Toxicity studies of Au-NPs opened a door for a new range
of antibacterial and antioxidant agents. Moreover, El-Kassas
and El-Komi [32] reported the biogenic Ag-NPs using the
green seaweed Ulva rigida and their fungicidal effects. The
authors reported the antifungal effect of the biogenic Ag-
NPs against a variety of pathogenic fungi. The cytotoxic
effects of the biosynthesized Ag-NPs against Artemia sp. have
been also reported. The results of the study revealed that mar-
ine algae can be used as a prototype for development of a
Figure 4 SEM micrograph showing morphology of Aspergillus fumigatus, (Left): Normal conidiophores and (Right): Conidiophores in
presence of Ag-NPs biosynthesized using Ulva rigida [31].
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fungal effect of biogenic Ag-NPs against Aspergillus fumigatus.
The antifungal effects of the biosynthesized Au-NPs using
the aqueous extract of the brown seaweed Dictyota bartayre-
siana were studied against Humicola insolens (Soft-rot fungus)
and Fusarium dimerum. The biosynthesized Au-NPs have very
effective antifungal properties as compared to chemically
synthesized antifungal drug [134]. Recently El-Sheekh and
El-Kassas [35], reported that phytogenic Au-NPs synthesized
from the marine alga Picochlorum sp. in combination with
ampicillin (10 lg), gentamicin (10 lg), and amphotericin B
(25 lg), exerted an outstanding antimicrobial effect and bio-
cide action against the tested Gram-positive, Gram-negative
bacteria and the tested fungal pathogens. The authors sug-
gested the phytogenic metal-based NPs due to their biophysi-
cal properties are as promising as antimicrobials and
therapeutic agents.
Kayalvizhi et al. [62] reported that the antibacterial activity
of NPs was more pronounced than antifungal activity when
they used brown seaweed mediated Ag-NPs and Au-NPs using
E. coli, S. aureus, Salmonella typhi and Pseudomonas aerugi-
nosa and the pathogenic fungi strains Candida albicans, Alter-
naria alternata, Penicillium italicum and Fusarium equiseti.
Considering the antiviral activity of Au-NPs, Kesarkar
et al. [63] investigated both Au-NPs alone and Polyethylene
Glycol coated Au-NPs (PEG-Au-NP) were permitted to inter-
act respectively with viral particles before infecting the cells
and to interact with HIV- infected CD4+ T cells as well. Their
results suggest that the Au-NPs are effective as both virus
entry inhibitors and virus neutralizing agent, whereas, Au-
PEG at 2 ppm and 4 ppm were more effective in obstructing
viral entry when interacted with viral particles directly.
Papp et al. [101] have described their studies in which func-
tionalized Au-NPs were used to inhibit the influenza virus and
they have proved that sialic-acid-functionalized Au-NPs are
able to effectively inhibit viral infection as settled [43].
Recently, Chiodo et al. [21] described the preparation and
characterization of 3 nm glucose-coated Au-NPs loaded with
anti-HIV ester pro-drug candidates. They concluded that, the
drugs were released from the glycol-NPs in acidic conditions
and were able to stop viral replication in cellular assays with
IC50 values similar to the free drugs. The drug delivery system
based on the coupling of ester derivatives onto gold glycol-NPs
is a promising strategy which opens the way to re-design more
complex Au-NPs with improved antiviral activity.3.2. Anti-cancer potential of silver and gold nanoparticles
Bioactive compounds in marine plants and algae have been
reported against various cancer cell lines. Cancer is one of
the major health problems worldwide; hence it is a challenge
to find drugs for the effective treatment of various types of
cancer. Sriram et al. [127] studied the biologically synthesized
silver NPs role as antitumor agents using Dalton’s lymphoma
ascites (DLA) cell lines in vitro and in vivo. The results showed
a decrease in the progressive development of tumor cells. They
suggested that this may be a cost-effective alternative in the
treatment of cancer and angiogenesis-related disorders. They
also added that the histopathology analysis of ascitic fluid
showed a reduction in DLA cell count in tumor-bearing mice
treated with Ag-NPs. Also, they explained that this may be
due to their inhibitory potentialities in several signaling cas-
cades that responsible for development and pathogenesis of
the disease. Moreover, they suggested that Ag-NPs can induce
cytotoxic effects on DLA cells, inhibiting tumor progression
and thereby effectively governing disease progression without
toxicity to normal cells. Martins et al. [86] explained that the
cytotoxic activity of silver is due to the active physicochemical
interaction of silver atoms with the functional groups of pro-
teins, as well as with the nitrogen bases and phosphate groups
in DNA. Furthermore, Youn-Jung et al. [138] studied the cyto-
toxicity and genotoxicity of nano-Ag in mammalian cell lines.
They demonstrated that the nano-compounds can induce pri-
mary DNA damage in animal cell cultures, notwithstanding
being incapable to induce mutagenicity.
During their study on the in vitro cytotoxic activity on
human Caucasian colon adenocarcinoma, Devi and Valentin
Bhimba [23], have found that Ag-NPs synthesized using the
seaweed Hypnea sp. are influenced by the dimensions of the
particles. The smaller the particles, the greater the effects.
Also, Devi et al. [24] studied the production of biogenic Ag-
NPs using aqueous extracts of the marine macro alga Sargas-
sum longifolium and its applications against Hep-2 cell line.
The in vitro screening of the biosynthesized nano-Ag
showed the potential cytotoxic activity against the carcinoma
Hep G2 cell lines was increased at higher concentrations, sug-
gesting that the cytotoxic activity may be due to the presence
of alkaloids present in the algae as indicated [31]. Mfouo-
Tynga et al. [88] studied the cytotoxic effects of Ag-NPs on
MCF-7 breast and A549 lung cancer cell lines using a variety
of assays.
Figure 5 Agarose gel electrophoretic analysis of DNA isolated
from MCF7 Cells incubated with different concentrations of Au-
NPs synthesized using Corallina officinalis aqueous extract. Lane1:
DNA ladder; Lane 2: control and Lane 3: 0.75 ll mL1; Lane 4:
0.375 ll mL1; Lane 5: 1.5 ll mL1; Lane 6: 3 ll mL1 and Lane
7: 6 ll mL1, respectively [31].
306 M.M. El-Sheekh, H.Y. El-KassasEl-Kassas and El-Sheekh [33] studied the cytotoxic effect of
biosynthesized gold NPs with an extract of the red seaweed
Corallina officinalis on the MCF-7 human breast cancer cell
line. They have reported that the nano-Au showed potent cyto-
toxic activity against MCF-7 cells, causing severe effect at high
concentrations while lower concentrations showed no effect as
determined by DNA fragmentation assay (Fig. 5).
3.3. Antibacterial mechanism of silver and gold nanoparticles
The nanosized-Ags of less than 20 nm diameters get attached
to sulfur-containing proteins of bacterial cell membranes
resulting in more permeability of the membrane, which causes
the death of the bacterial cells as reported by Morones et al.
[93]. This process seems to be dose dependent. The lethal
effect of Ag-NPs (in the size range of 10–15 nm) on both
the Gram-negative and Gram-positive bacteria has been
reported [120].
Morones et al. [93], explained that the bactericidal effect of
Ag-NPs could be attributed to either their interaction with the
surface of membrane as well as to their penetration inside the
bacteria. However, Kimet al. [64], studied antibacterial mech-
anism of Ag-NPs for certain microbial species. They concluded
that, peptidoglycan layer is a specific membrane character of
bacterial species and not mammalian cells. Therefore, if the
bactericidal effect of Ag-NPs is linked to this layer, it will be
easier and more specific to use Ag-NPs as an antibacterial
agent. In addition, Rai and Jamuna Bai [105] stated that bac-
tericidal activity of silver ions is higher in case of Gram-
negative bacteria. This might be due to the thickness of the
peptidoglycan layer in the cell wall of Gram-positive bacteria
which may prevent to some extent the action of the silver ions
as reported [39].
Sondi and Salopek-Sondi [124] reported that the bacterici-
dal activity of Ag-NPs on Gram-negative bacteria was dose
dependent, and was closely associated with producing of ‘pits’
in the cell wall of bacteria. Then, Ag-NPs accumulated in the
bacterial membrane, leading to cell death and they reported
degradation of the membrane structure of microorganism withAg-NPs. Other studies suggested the effect of Ag-NPs on the
cell morphology of both E. coli and S. aureus as it has been
reported using TEM, SEM and X-ray microanalyses [39,59].
Similar morphological changes in the Gram-positive as well
as Gram-negative bacteria have been reported upon the treat-
ment with the silver ions.
Kim et al. [64] suggested that the antimicrobial mechanism
of Ag-NPs is related to the formation of free radicals and free
radical-induced membrane damage. The free radicals may be
derived from the surface of Ag-NPs and be responsible for
the antibacterial activity. Moreover, Kvitek et al. [71]
explained that the attachment of Ag-NPs to the cell surface
resulting in disturbing permeability and respiration functions
of the cell. They added that the smaller Ag-NPs have the large
surface area available for interaction would give more bacteri-
cidal effect. The mode of the bactericidal activity of Ag-NPs is
dependent on the source from which the particles are derived.
Small size NPs may penetrate the cell membranes. Inside a
bacterium, NPs can interact with DNA, thus failure in its abil-
ity to replicate which may lead to the cell death [106]. Rai and
Jamuna Bai [105] revealed that the recent studies have demon-
strated that Ag-NPs of less than 10 nm diameter make pores
on the bacterial cell walls. The cytoplasmic content is released
to the medium, leading to cell death [124].
Through transcriptomic and proteomic approaches, Cui
et al. [22] found that Au-NPs exert their antibacterial activity
mainly through two ways: one is to change membrane poten-
tial and stop ATP synthase activities to decrease the ATP level,
indicating a general decline in metabolism. The other way is to
prevent the subunit of ribosome for RNA binding, indicating a
collapse of biological process. Gold NPs also enhance chemo-
taxis in the early-phase reaction. The multiple targets of action
could help Au-NPs to fight effectively against multi drug resis-
tant bacteria. In addition, a striking finding is that bactericidal
Au-NPs did not induce any reactive oxygen species (ROS)
related process, while the generation of ROS is the cause of cel-
lular death for most bactericidal antibiotics and other antibac-
terial nanomaterials.
The improvement of antimicrobial activities of Ag-NPs at
lower concentrations can be carried out using composites of
Ag-NPs with polymer [5,87,67]. Chitosan, a cationic polysac-
charide has been reported to be used in the form of composite
with Ag-NPs with high antimicrobial efficacies. Rai and
Jamuna Bai [105] tipped-off that the chitosan Ag-NPs compos-
ite have further improved the antimicrobial quality than its
individual components i.e. chitosan and silver. On using this
type of composites, the positively charged chitosan matrix hold
negatively charged bacteria on its surface, while small sized
Ag-NPs created pits on bacterial wall, therefore causing rapid
death of the bacteria [6].
3.4. Antifungal mechanisms of silver nanoparticles
The mechanism of inhibitory action of Ag-NPs on microor-
ganisms could be by their adhesion to the cell membrane
and penetration inside or by interaction with phosphorus con-
taining compounds like DNA upsetting the replication process
or preferably by their attack on the respiratory chain. It has
also been suggested that a strong specific cellular response
takes place between the silver ions and thiol groups of vital
enzymes thus inactivating them [26,108].
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ability by the DNA when treated with silver ions which results
in loss of cell viability and eventually resulting in cell death
[46,104]. Moreover, Dorauet al. [26] reported that Ag-NPs
exhibit the antifungal potentialities due to the production of
insoluble compounds though inactivation of sulfhydryl groups
in the fungal cell wall and disruption of membrane bound
enzymes and lipids resulting in lyses of cell. Nano-silver has
been reported to inhibit yeast like fungi.
The mode of action of Ag-NPs on fungi is by targeting the
yeast cell membranes and disrupting membrane potential. The
transmission electron microscopy analysis has revealed that
the interaction between nano-silver and the membrane struc-
ture of Candida albicans cells during nano-silver exposure
results in changes in the membranes of C. albicans, which
can be observed as the ‘‘pits” on the cell surface. The forma-
tion of pits subsequently leads to cell death [42].
3.5. Antiviral mechanisms of metal nanoparticles
Galdiero et al. [43] stated that in addition to the direct interac-
tion with viral surface glycoprotein, metal NPs may gain access
into the cell and exert their antiviral effects through interac-
tions with the viral genome (DNA or RNA). Furthermore,
the intracellular apartment of an infected cell is overcrowded
by virally encoded and host cellular factors that are required
to allow viral replication and a proper production of progeny
virions as reported by Lu et al. [83].
The interaction of metal NPs with these factors, which are
the key to an efficient viral replication, may also represent a
further mechanism of action. Most of the published literature
describes the antiviral activity of silver or gold NPs against
enveloped viruses, with both a DNA and RNA genome. Con-
sidering that one of the main arguments toward the efficacy of
the analyzed NPs is the fact that they in virtue of their shape
and size, can interact with virus particles with a well-defined
spatial arrangement, the possibility of metal NPs being active
against naked viruses seems appealing [43].4. Additional applications of silver nanoparticles
The Ag-NPs have a number of applications mainly pharma-
ceutical and medical diagnosis and therapy. Nano silver in
the form of colloidal silver has been used for long time in
the United States since 1954 and has been registered as a bio-
cidal material [97]. The emergence of antibiotic- and/or
multidrug-resistant bacteria is identified as a crucial challenge
for public health. In order to control and Kill the antibiotic-
resistant bacteria multiple, high-priced drugs are required that
may have side effects. As a result, treatments are expensive and
require more time. The NPs can offer a new strategy to tackle
multidrug-resistant bacteria [77]. The Ag-NPs are attractive
options because they are not poisonous to the human body
at low concentrations and in addition they have broad spec-
trum antibacterial actions. The antibacterial activity of silver
ions is well known, however, the bactericidal activity of ele-
mentary silver, in the form of NPs has been developed. The
antimicrobial activity of Ag-NPs was investigated against
yeast, E. coli, and S. aureus as indicated by [13].Galdiero et al. [43] stated that the bactericidal activity of
nano-silver was demonstrated by in vitro experiments. Bacteri-
cidal activity against methicillin-resistant S. aureus (MRSA)
[99], the Gram- negative E. coli [124,93,98,137], P. aeruginosa
and Vibrio cholera [93] as well as B. subtilis has been reported.
Synergistic antimicrobial activity of Ag-NPs with different
antibiotics against S. aureus, E. coli, S. typhi and Micrococcus
luteus was reported [118,7,38]. Rai and Jamuna Bai [105] stated
that nano sized silver have been studied to produce composites
for use as disinfecting filters and coating materials and as a
medium for antibiotic delivery [80,114,64].
Generally, antimicrobial activity of chitosan has been
demonstrated against different bacteria, filamentous fungi and
yeasts [49], however, the antimicrobial properties can be
improved using combinations of chitosan and silver. Silver-
chitosan nanocomposites that stopped the growth of S. aureus
and E. coli were prepared by [13]. Moreover, these materials
were suggested by Sanpui et al. [117] as coatings for
biomedical-engineering and food-packaging applications.
Other workers prepared silver-chitosan films that killed S. aur-
eus, and also proposed them for food packaging [25]. Using an
alternative layer-by-layer construction that was proposed for
coating cardiovascular implants Fu et al. [40] prepared multi-
layer films containing nano-Ag and chitosan, that were effective
against E. coli.
Galdiero et al. [43] mentioned that the Ag-NPs have found
different applications in the form of wound dressings; Ag-NPs
impregnated textile fabrics [65,131]. Nano-Ag materials are
extensively used in the medications of burns, various ulcers
(e.g., rheumatoid arthritis-associated leg ulcers and diabetic
ulcers), toxic epidermal necrolysis, in surgical mesh, surgical
masks, coating of catheters and other implantable medical
devices to inhibit the growth of slime-containing biofilms that
promote bacterial infection and sepsis. The ability to retard
polymerization of fibrin and further prevention of formation
of clot was reported [41,72,121].
Most of the nano-Ag applications are silver-impregnated
water filters, algaecide and antimicrobial additives that do
not claim to contain NPs [97]. El-Sheekh and El Kassas [34]
reported the algaecide effect of the biosynthesized Ag-NPs
using a variety of microalgae against Microcystis aeruginosa
which is a Microcystin producing cyanobacterium. This alga
is the most common bloom-forming species which is enhanced
due to anthropogenic activities along with deficient water man-
agement [14]. El-Sheekh and El Kassas [34] reported the toxic
potentialities of the biosynthesized Ag-NPs against the toxic
cyanobacteriumM. aeruginosa. The results showed high reduc-
tion in viable cell count and the total chlorophyll content.
They added that the potential activity of the biosynthesized
silver-NPs from the studied algal species againstM. aeruginosa
cells is expected to be mainly mediated by the release of silver
ions (Ag+) from the particle surface and the biologically active
compounds in the microalgae as indicated by FTIR analyses.
5. Additional applications of gold nanoparticles
Several important applications of nano-gold have been
reported. Gu et al. [47] have proved that Au-NPs in toluene
react with bis (vancomycin) cystamide in water under robust
stirring conditions to form vancomycin-capped Au-NPs; the
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activity against E. coli strains.
Nanosized-Au particles based probes have been used for
the identification of pathogenic bacteria in DNA-microarray
technology. The ability to modulate the surface chemistry of
Au-NPs by binding suitable ligands has important applications
in many areas such as novel drug/DNA delivery and imaging
[69].
Nano scale-gold is capable of delivering large biomolecules
(peptides, proteins, or nucleic acids like DNA or RNA) [44].
The Au-NPs are utilized to facilitate the specific interactions
between anticancer drugs and DNA. Additionally, Shen
et al. [119] indicated that Au-NPs can be applied to amplify
the biorecognition of the anticancer. Dacarbazine [5-(3,3-
dimethy-1-triazenyl) imidazole-4-carboxamide;DTIC] is a
commonly used anticancer drug. The oxidized DTIC is posi-
tive charged. Thus, DTIC could be easily assembled onto the
surface of negatively charged Au-NPs. The specific interac-
tions between anticancer drug DTIC and/or DNA bases were
facilitated by Nano sized gold.
A highly efficient drug vector for photodynamic therapy
(PDT) drug delivery was developed by synthesizing PEGylated
Au-NP conjugates, which act as a water-soluble and biocom-
patible ‘‘cage” that allows delivery of a hydrophobic drug to
its site of action. The mechanisms of drug release in vitro in
a two-phase solution system and in vivo in cancer-bearing mice
reveals that the process of drug delivery are highly efficient,
and passive targeting prefers the tumor site. As for the Au
NP–Pc 4 conjugates, the time required for PDT to be delivered
has been noticeably reduced to less than 2 h, while the free
drug took 2 days to be delivered [19].The cytotoxic drug cis-
platin was adsorbed on Au–Au2S NPs via 11 mercaptounde-
canoic acid layers [109].6. Conclusions
The increase in incidence of drug resistance and emerging
infectious diseases among pathogenic bacteria has made the
search for new bactericidal agents necessary, so does the fatal
disease caner. The growing needs for the biosynthesis of ther-
apeutics of biological origin is a must. One of the most promis-
ing and novel therapeutic agents are the metal NPs. The
unique biophysical properties of the nano-Ag and the nano-
Au exhibit inhibitory capacity against microbes which ease
the application of NPs as antimicrobials and drug deliveries.
Marine algae are divided into two groups, namely microalgae
and macro algae (seaweeds). Their phytochemicals such as
hydroxyl, carboxyl, and amino functional groups, can serve
as effective metal-reducing besides capping agents to provide
a robust coating on the metal NPs. Biosynthesis of nanoparti-
cles using green resources is a simple, environmentally friendly,
pollutant-free and low-cost approach. This green method of
synthesizing Ag-NPs could also be extended to produce other
important metal NPs.Acknowledgments
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